275 related articles for article (PubMed ID: 25314967)
1. Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function.
Liu X; Pasula S; Song H; Tessneer KL; Dong Y; Hahn S; Yago T; Brophy ML; Chang B; Cai X; Wu H; McManus J; Ichise H; Georgescu C; Wren JD; Griffin C; Xia L; Srinivasan RS; Chen H
Sci Signal; 2014 Oct; 7(347):ra97. PubMed ID: 25314967
[TBL] [Abstract][Full Text] [Related]
2. Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes.
Wu H; Rahman HNA; Dong Y; Liu X; Lee Y; Wen A; To KH; Xiao L; Birsner AE; Bazinet L; Wong S; Song K; Brophy ML; Mahamud MR; Chang B; Cai X; Pasula S; Kwak S; Yang W; Bischoff J; Xu J; Bielenberg DR; Dixon JB; D'Amato RJ; Srinivasan RS; Chen H
J Clin Invest; 2018 Aug; 128(9):4025-4043. PubMed ID: 30102256
[TBL] [Abstract][Full Text] [Related]
3. CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling.
Qin L; Zhang H; Li B; Jiang Q; Lopez F; Min W; Zhou JH
Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):2943-2960. PubMed ID: 34670407
[TBL] [Abstract][Full Text] [Related]
4. Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.
Tessneer KL; Pasula S; Cai X; Dong Y; McManus J; Liu X; Yu L; Hahn S; Chang B; Chen Y; Griffin C; Xia L; Adams RH; Chen H
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):331-337. PubMed ID: 24311377
[TBL] [Abstract][Full Text] [Related]
5. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
6. Epsins Negatively Regulate Aortic Endothelial Cell Function by Augmenting Inflammatory Signaling.
Dong Y; Wang B; Cui K; Cai X; Bhattacharjee S; Wong S; Cowan DB; Chen H
Cells; 2021 Jul; 10(8):. PubMed ID: 34440686
[No Abstract] [Full Text] [Related]
7. VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling.
Harris NR; Nielsen NR; Pawlak JB; Aghajanian A; Rangarajan K; Serafin DS; Farber G; Dy DM; Nelson-Maney NP; Xu W; Ratra D; Hurr SH; Qian L; Scallan JP; Caron KM
Circ Res; 2022 Jan; 130(1):5-23. PubMed ID: 34789016
[TBL] [Abstract][Full Text] [Related]
8. VEGFR3 is required for button junction formation in lymphatic vessels.
Jannaway M; Iyer D; Mastrogiacomo DM; Li K; Sung DC; Yang Y; Kahn ML; Scallan JP
Cell Rep; 2023 Jul; 42(7):112777. PubMed ID: 37454290
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
11. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
12. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.
Petrova TV; Karpanen T; Norrmén C; Mellor R; Tamakoshi T; Finegold D; Ferrell R; Kerjaschki D; Mortimer P; Ylä-Herttuala S; Miura N; Alitalo K
Nat Med; 2004 Sep; 10(9):974-81. PubMed ID: 15322537
[TBL] [Abstract][Full Text] [Related]
13. Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth.
Urner S; Planas-Paz L; Hilger LS; Henning C; Branopolski A; Kelly-Goss M; Stanczuk L; Pitter B; Montanez E; Peirce SM; Mäkinen T; Lammert E
EMBO J; 2019 Jan; 38(2):. PubMed ID: 30518533
[TBL] [Abstract][Full Text] [Related]
14. Mechanical forces and lymphatic transport.
Breslin JW
Microvasc Res; 2014 Nov; 96():46-54. PubMed ID: 25107458
[TBL] [Abstract][Full Text] [Related]
15. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells.
Suzuki H; Watabe T; Kato M; Miyazawa K; Miyazono K
Blood; 2005 Mar; 105(6):2372-9. PubMed ID: 15561887
[TBL] [Abstract][Full Text] [Related]
16. Profibrotic VEGFR3-Dependent Lymphatic Vessel Growth in Autoimmune Valvular Carditis.
Osinski V; Yellamilli A; Firulyova MM; Zhang MJ; Peck AL; Auger JL; Faragher JL; Marath A; Voeller RK; O'Connell TD; Zaitsev K; Binstadt BA
Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):807-821. PubMed ID: 38269589
[TBL] [Abstract][Full Text] [Related]
17. The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.
Monaghan RM; Page DJ; Ostergaard P; Keavney BD
Cardiovasc Res; 2021 Jul; 117(8):1877-1890. PubMed ID: 33067626
[TBL] [Abstract][Full Text] [Related]
18. Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.
Dashkevich A; Raissadati A; Syrjälä SO; Zarkada G; Keränen MA; Tuuminen R; Krebs R; Anisimov A; Jeltsch M; Leppänen VM; Alitalo K; Nykänen AI; Lemström KB
Am J Transplant; 2016 Apr; 16(4):1160-72. PubMed ID: 26689983
[TBL] [Abstract][Full Text] [Related]
19. Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.
Pasula S; Cai X; Dong Y; Messa M; McManus J; Chang B; Liu X; Zhu H; Mansat RS; Yoon SJ; Hahn S; Keeling J; Saunders D; Ko G; Knight J; Newton G; Luscinskas F; Sun X; Towner R; Lupu F; Xia L; Cremona O; De Camilli P; Min W; Chen H
J Clin Invest; 2012 Dec; 122(12):4424-38. PubMed ID: 23187125
[TBL] [Abstract][Full Text] [Related]
20. Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1.
Ma Z; Yu YR; Badea CT; Kovacs JJ; Xiong X; Comhair S; Piantadosi CA; Rajagopal S
Circulation; 2019 Mar; 139(13):1629-1642. PubMed ID: 30586762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
